Newsletter | August 21, 2024

08.21.24 -- How Doubly Labeled Water Can Improve Data In Metabolic Disease Research

SPONSOR

Webinar: Unleash the Power of IQVIA eCOA: A Deep Dive

As clinical trials increasingly rely on patient-focused outcomes data, it’s crucial to understand the latest features and best practices for eCOA platforms. In this session, IQVIA eCOA expert Edward Bartels will provide an overview of the eCOA landscape and how to effortlessly create a diary, schedule site/participant assessments, and manage translations and compliance. Click here to learn more

DECENTRALIZED TRIALS

At-Home Microdosing Trial Examines Sub-Hallucinogenic Doses For Depression

Guest Column | A conversation with MindBio Therapeutics CEO Justin Hanka

MindBio Therapeutics CEO Justin Hanka details the company’s Phase 2a clinical trial investigating the use of a take-home microdosing regimen for depression.

Site Support: The Cornerstone Of The Digital Trial Evolution

Webinar | IQVIA Research & Development Solutions

Follow along as this panel of experts shares key insights from their experiences, highlighting the technologies and processes that lead to successful partnerships in patient-centric digital trials.

TRIAL MANAGEMENT

How Doubly Labeled Water Can Improve Data In Metabolic Disease Research

Guest Column | By Hari Mix and Erica Svendahl, Calorify

Energy imbalance is at the root of metabolic disease, yet it isn’t being measured. The DLW method offers assesses total energy expenditure, energy intake, and body composition for clinical and research evaluations. 

Myasthenia Gravis: Reducing Outcome Measures Variability In Trials

Article | By Lewis M. Fredane and Marta Pereira, Signant Health

MG is a rare autoimmune disease often unknown to the public. Here, we explore its history, treatment progress, study challenges, and strategies to reduce outcome variability.

Insights Into Radiopharmaceuticals: Global Clinical Research Overview

Article | Novotech

This in-depth analysis offers invaluable insights into the evolving field of innovative cancer therapies, addressing your critical questions.

Streamlining Study Start-Up For Accelerated Drug Development

Case Study | Altasciences

Delve into the details of how we accelerated a Phase 1 study’s start-up time by 70%. This study shares insights on streamlining communication, strategic planning, and more.

Accelerating Site Activation: Examples From Novartis And IQVIA

Article | By Rosemary Shirey, IQVIA Technologies

As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.

A Site's Point Of View Into Study Start-Up

Article | By Kristin Surdam, Florence Healthcare

Learn how sites can enhance their ability to meet start-up timelines, positively impacting both operational efficiency and patient outcomes.

New Is Risky. Start With A Free Feasibility Report.

Brochure | palleos healthcare

Get a free preliminary evaluation of your protocol design from a leading CRO in Eastern Europe.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: